Vote Billy-boy onto Cramer's Wall of Shame

Good old Billy Boy was nominated as one of 10 CEO's to be put onto Jim Cramer's Wall of Shame.

Cast your vote for Billy!
http://www.cnbc.com/id/38525033

 

Check the link. It looks like our CEO is leading for the worst of the worst!

 

It's a close race.

 

Billy Boy knows how to charm the BOD. Unlike Larsen, who was all business, Billy Boy is the most competitive guy going. That would be great if the competitiveness was with other companies, (well besides Amgen) but it is within J&J. Yes men/women get promoted.

 

thanks, i clicked the link and cast my vote. time to pay the piper billy

 

Come on all you JnJer's out there! Current and Kicked out folks! Here' s your chance to get Willie an honor he truly deserves! Vote now! He's neck and neck with another horrible CEO! Let's push Willie over the top! Vote! Vote! Vote!

 

Looks like Billy is falling behind. There's another CEO getting many more votes. How can anyone be worst than Billy??? I'm going to see if I can vote again.

 

Willie came in 2nd to the Air Tran guy. Willie, in our hearts and minds, you will always be #1 worst CEO.

 

and he ended 7th - see http://www.cnbc.com/id/38559120/?slide=7
What an achievement Billy, scoring 7th worst CEO, upon inheriting a once famous and revered company. This is not even below par; it is just unPARallelled.
Better retire quickly before it gets even worse... What anembarassement when you make it to first place next time...

 

Cramer couldn't take Weldon's incompetence any longer so he is now on Mad Money's Wall of Shame. Cramer asked that the board remove him for ruining a great company. With over 15 product recalls since 09 his time has passed

What's taking so long Board of Directors???

Watch it here:

http://www.cnbc.com/id/40700552?__so...t%7C&par=yahoo

 

From the Motley Fool

The Road to a Ruined Reputation
By Alyce Lomax | More Articles
December 10, 2010 | Comments (10)

JNJ
Johnson & Johnso

Watch JNJ CAPS Rating 5/5 Stars . $62.54 $0.14 (0.22%)


More about JNJ
Is Intuitive Surgical the Perfect Stock?
Here's How Forest Laboratories May Be Failing You
BROWSE ALL JNJ ARTICLES
Don't let it get away!Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

•Click Here Now
Johnson & Johnson (NYSE: JNJ) enjoys a prestigious image. Its cursive logo brings to mind Band-Aids, no-bawling baby shampoo, and many other comforting products found in every medicine cabinet. For years, it's often scored highly on consumer opinion polls -- but that may be about to change.

How much tarnishing can a reputation take before it's ruined entirely? As Johnson & Johnson suffers through a long, disturbing string of recalls, investors should seriously ask themselves how the company's management ever let quality control slip so disastrously.

Trying to find who you can trust
Johnson & Johnson scores very well on Harris Interactive's U.S. Reputation Quotient, and a recent public opinion poll by Boston College's Center for Corporate Citizenship and the Reputation Institute ranked Johnson & Johnson alongside Walt Disney (NYSE: DIS) and Kraft Foods (NYSE: KFT) atop a list of companies regular people find most "socially responsible."

Unfortunately, those glowing poll numbers may no longer reflect reality. Quality problems have forced Johnson & Johnson to recall more than 40 medicines this year, including common household names such as Motrin and Tylenol.

Just yesterday, Johnson & Johnson announced a recall of 13 million packages of Rolaids soft chews. In addition to gastrointestinal relief, users have complained that these tablets include a little bonus: metal and wood particles.

Johnson & Johnson shareholders should have a blazing stomachache over this situation. This is a company whose entire brand is supposed to elicit a feeling of being comforted -- of feeling better. Wood and metal in your medicine provide no such reassurance.

Even more mind-bogglingly, Johnson & Johnson CEO William Weldon made the Institute for Policy Studies' eye-opening September report on "Layoff Leaders." He took home $25.6 million in compensation in 2009, even as Johnson & Johnson dismissed 9,000 employees from its payrolls. Even then, the company had begun to show plenty of signs of serious quality control problems.

Different routes to ruin
Some reputation-destroyers are abrupt and dramatic. The Deepwater Horizon disaster and subsequent Gulf Oil spill did serious, lightning-fast reputational damage to BP (NYSE: BP).

And it probably came as little surprise to anybody that AT&T (NYSE: T) was recently named the worst-rated cellular carrier, based on a survey of 58,000 of Consumer Reports readers. Apparently, everybody hates AT&T.

Such widespread loathing is a clear and obvious risk to long-term shareholders. Corporate lore is full of examples of companies that rested on old laurels, abused customers, suffered reputational deterioration, and then lost big to rivals.

Netflix's amazing success probably owed in large part to Blockbuster's inability to make its own customers happy, which created a perfect storm of ill will over many years. Fed up with Blockbuster's limited selection and punishing late fees, folks were more than ready to try out a new, exciting rival that was changing all the rules. Look where Blockbuster is now.

When trust finally requires proof
So far, it seems like everybody -- most likely including most of its investors -- believes that Johnson & Johnson's enormous brand power can withstand any storm. But no company's brand is bulletproof, and investors should never assume that public sentiment won't change.

At some point, folks might take off the rose-colored glasses and ask themselves whether they can really trust this company. And when the Band-Aid comes off, things could get painful and ugly for shareholders who've always assumed that Johnson & Johnson is one of the healthiest stocks in the marketplace.

Check back at Fool.com every Wednesday and Friday for Alyce Lomax's columns on corporate governance.

Closed since June 2009 – Open 7 days only. Get notified ahead of time as professional investor Jeff Fischer manages a $1 MILLION long/short, real-money portfolio of stocks, options, and ETFs. This is the first open since June 2009, by invitation only. Enter email below.


.Alyce Lomax does not own shares of any of the companies mentioned. Walt Disney is a Motley Fool Inside Value recommendation. Walt Disney and Netflix are Motley Fool Stock Advisor recommendations. Motley Fool Options has recommended a diagonal call position on Johnson & Johnson, which is a Motley Fool Income Investor recommendation. The Fool owns shares of Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Read/

 

Who do you think the chairman of the Board is?

 

The head of a corporation can still be removed even if he is both Chairman and CEO.

Just as the BOD voted to appoint they can typically motion to remove a Chairman and/or CEO that is not performing. If these recalls continue, as Cramer stated, the FDA may send a letter asking for a leadership change.

However, voluntary retirement would be better for all.

 

The chairman is ol blue eyes......Frank Burns

 

Can you believe this clown sends out a video for the 125th anniversary showing all the great things J&J has done, as if he had something to do with any of it!! He wonders what his legacy is??? Hey Willie your legacy can be seen in every pharmacy across the nation. That empty space where tylenol, benadryl, rolaids and other JnJ products used to be, is your legacy....You are truly THE worst leader this company has ever seen, to show a clip of Larson in a video you narrate is a disgrace, you couldnt shine Larson's shoes